-
Study aim
-
Investigating the effectiveness of using digital health monitoring tools on improving physical health indicators and medication adherence in the elderly
-
Design
-
A randomized, single-blind, parallel-group, controlled clinical trial on 80 individuals over 60 years of age.
-
Settings and conduct
-
This randomized controlled trial enrolls adults ≥60 years attending six Tehran Oil Industry family health centers. Participants are selected through stratified random sampling proportional to each center’s share and gender balance, yielding 80 individuals. Assignment to the intervention (40) and control (40) groups uses stratified-block randomization by an independent statistician with allocation concealment via opaque numbered envelopes. Because the intervention—a digital package with a smartwatch and mobile app—cannot be blinded to participants, only the outcome assessor and statistical analyst are blinded. The 12-week intervention includes training, technical support, and adherence monitoring through weekly reports and motivational calls. Measurements are obtained at baseline and every two weeks using questionnaires, blood pressure/glucometer readings, and wearable-device data, and analyses employ appropriate statistical tests such as paired/independent t-tests, chi-square, and multivariate regression.
-
Participants/Inclusion and exclusion criteria
-
People aged 60 and over who visit family health centers and are literate or have a caregiver are included in this plan, and those who do not cooperate or have cognitive impairments are excluded.
-
Intervention groups
-
In the intervention group, people use a digital watch with a medication reminder app, a pedometer, and a heart rate monitor. The control group receives only usual care.
-
Main outcome variables
-
Fasting blood sugar; medication adherence; satisfaction with technology; use of devices, diastolic and systolic blood pressure.